Explore the Global Marburg Virus Disease Therapeutics Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

Marburg Virus Disease Therapeutics Market

Key Insight

Marburg virus disease therapeutics sales will grow through 2036, led by antibiotics at 34.2% of the drug classification segment in 2026. The market was valued at USD 100.90 million in 2025 and is expected to be worth USD 172.57 million by 2036, creating an incremental opportunity of USD 66.62 million.

April 28, 2026

Anurag Sharma

301 Pages

Cite this Report

Marburg Virus Disease Therapeutics Market

https://www.futuremarketinsights.com/reports/marburg-virus-disease-therapeutics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

BioCryst Pharmaceuticals
Emergent BioSolutions Inc
Gilead Sciences
Inovio Pharmaceuticals
Moderna
Regeneron Pharmaceuticals
Tonix Pharmaceuticals
Vaxart

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Marburg Virus Disease Therapeutics Market

Key Players

Similar Industry Reports